Advances in Hematological Malignancies
Recent years have witnessed remarkable advancements in the domain of hematological malignancies. Novel treatment modalities such as targeted agents, immunotherapies, and therapy are altering the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative approaches, offering promise for more curative